US President Donald Trump has unveiled a phased tariff plan for imported generic drugs. The announcement has put Indian pharma stocks such as Sun Pharma, Dr Reddy's Laboratories, Cipla, Lupin and Aurobindo Pharma in focus,

US President Donald Trump announced that imported generic drugs will face 0% tariffs for two years starting August 1, followed by 100% and 200% tariffs to encourage domestic production and reduce reliance on imports.

The Trump administration is preparing fresh tariffs on imports from dozens of countries, a move that could reshape global trade, raise prices and trigger new trade disputes.

Add Yahoo as a preferred source to see more of our stories on Google. President Donald Trump slapped a 15% tariff on nearly all imports and promised a flurry of additional measures in response to the recent Supreme Court ruling that struck down his ...

From Monday, US businesses that paid tariffs later ruled illegal can begin asking for refunds. The system will open at 8 am through an online portal run by US Customs and Border Protection. The development comes after a long legal fight over tariffs ...

In a post on Truth Social, the US President wrote that all generic drugs being brought into the US will have no tariffs for a two year period. Following which, the tariff will be raised to 100% from August 1,

The trouble here is that the reversal is dressed up in the same language as the original behavior.

Temu is using warehouses in the US to avoid those nasty import fees. I placed a new order. Maybe my love affair with cheap junk isn't over just yet.